Celgene, BMS, Teva Can't Pause Cancer Drugs Antitrust Suit
A New Jersey federal magistrate judge refused Friday to pump the brakes on consolidated antitrust lawsuits accusing Celgene and parent Bristol-Myers Squibb of conspiring with generic drugmakers Teva and Natco to...To view the full article, register now.
Already a subscriber? Click here to view full article